IRIS
DE LUCA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.098
AS - Asia 2.808
NA - Nord America 2.278
SA - Sud America 1.008
AF - Africa 90
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.287
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.264
US - Stati Uniti d'America 2.165
SG - Singapore 1.273
BR - Brasile 836
CN - Cina 507
HK - Hong Kong 507
IT - Italia 309
VN - Vietnam 142
FR - Francia 118
DE - Germania 92
IN - India 75
IE - Irlanda 65
BD - Bangladesh 58
GB - Regno Unito 57
AR - Argentina 56
MX - Messico 50
CA - Canada 42
AT - Austria 37
NL - Olanda 35
ZA - Sudafrica 35
IQ - Iraq 33
EC - Ecuador 30
TR - Turchia 30
CO - Colombia 24
PK - Pakistan 24
FI - Finlandia 23
SE - Svezia 19
UZ - Uzbekistan 18
CL - Cile 17
ID - Indonesia 17
UA - Ucraina 17
SA - Arabia Saudita 16
VE - Venezuela 16
JP - Giappone 15
PL - Polonia 15
ES - Italia 13
PH - Filippine 13
MA - Marocco 12
PE - Perù 12
MY - Malesia 11
JO - Giordania 10
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
IL - Israele 8
PY - Paraguay 8
KE - Kenya 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
DO - Repubblica Dominicana 5
LB - Libano 5
LT - Lituania 5
UY - Uruguay 5
AU - Australia 4
JM - Giamaica 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CH - Svizzera 3
DZ - Algeria 3
NP - Nepal 3
PA - Panama 3
QA - Qatar 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MT - Malta 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
Totale 9.276
Salva come PNG Salva come JPEG
Città #
Moscow 736
Ashburn 686
Singapore 529
Hong Kong 504
Dallas 312
San Jose 264
The Dalles 108
Beijing 104
Los Angeles 98
Lauterbourg 81
Dublin 64
Messina 56
São Paulo 52
Ho Chi Minh City 50
Buffalo 44
New York 43
Catania 39
Redondo Beach 39
Hanoi 37
Frankfurt am Main 33
Rio de Janeiro 33
Paternò 30
Belo Horizonte 27
Hyderabad 26
Munich 26
Santa Clara 26
Guangzhou 25
Mexico City 24
Orem 23
Tianjin 23
Vienna 23
Amsterdam 22
Boardman 21
Johannesburg 21
Shanghai 18
Turin 18
Brooklyn 16
Dhaka 16
Nuremberg 16
Porto Alegre 16
Tashkent 15
Chennai 14
Chicago 14
Manchester 14
Montreal 14
Tokyo 14
Council Bluffs 13
Guayaquil 12
San Francisco 12
Warsaw 12
Caxias do Sul 11
Chandler 11
Curitiba 11
Shenzhen 11
London 10
Quito 10
Ribeirão Preto 10
Amman 9
Atlanta 9
Baghdad 9
Helsinki 9
Medellín 9
Milan 9
Phoenix 9
Toronto 9
Abidjan 8
Ankara 8
Baku 8
Boston 8
Campinas 8
Kuala Lumpur 8
Prineville 8
Chongqing 7
City of London 7
Franca 7
Goiânia 7
Haiphong 7
Istanbul 7
Lappeenranta 7
Lima 7
New Delhi 7
Riyadh 7
Santo André 7
Seattle 7
Stockholm 7
Washington 7
Biên Hòa 6
Caracas 6
Florianópolis 6
Guarulhos 6
Houston 6
Jaipur 6
Lahore 6
Maceió 6
Nairobi 6
Salvador 6
Santiago 6
Sumaré 6
Bangkok 5
Buenos Aires 5
Totale 4.845
Salva come PNG Salva come JPEG
Nome #
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 190
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 175
Immature platelet fraction and the extent of coronary artery disease: a single centre study 150
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 149
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 144
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 118
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 106
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 106
A meta-analytic overview of thrombectomy during primary angioplasty 102
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 99
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 94
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 87
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 84
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 84
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 83
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 81
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 81
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 80
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 79
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 79
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 79
Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention 77
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 76
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 76
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 76
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 76
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 76
Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention 75
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 75
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 74
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 74
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 74
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 74
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 73
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 73
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 73
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 73
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 72
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 72
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 72
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 72
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 72
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 72
An unusual case of ECG ST-segment elevation 71
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 71
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 71
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 71
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 71
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 70
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 70
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry 70
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 70
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 70
Immature platelet fraction and the extent of coronary artery disease: A single centre study 70
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 70
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 70
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 69
Adjunctive antithrombotic therapy during Primary PCI 69
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 69
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 69
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 69
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 68
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 68
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 68
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 67
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 67
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 67
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 67
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 67
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 66
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease' 66
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 65
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 65
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 65
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 64
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers 64
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 64
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial 64
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 63
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 63
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 63
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 63
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 62
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 61
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 60
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 59
Switching from clopidogrel to prasugrel in patients having coronary stent implantation 59
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 58
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 58
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 58
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 58
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 57
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 57
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 56
Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography 56
Smoking and infarct size among STEMI patients undergoing primary angioplasty 55
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 55
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale 54
Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI 54
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation 54
Totale 7.542
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 1 1
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023708 2 3 1 4 4 5 3 4 11 473 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/20252.566 21 27 28 176 142 106 90 338 621 152 321 544
2025/20266.191 310 478 454 327 493 1.269 977 770 786 327 0 0
Totale 9.882